Australia - English - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - lorlatinib, quantity: 100 mg - tablet, film coated - excipient ingredients: sodium starch glycollate; magnesium stearate; microcrystalline cellulose; calcium hydrogen phosphate; titanium dioxide; lactose monohydrate; hypromellose; triacetin; iron oxide red; macrogol 3350; iron oxide black - lorviqua is indicated for the treatment of patients with anaplastic lymphoma kinase (alk)-positive locally advanced or metastatic non-small cell lung cancer (nsclc), as determined by a validated test.

Australia - English - Department of Health (Therapeutic Goods Administration)

chiesi australia pty ltd - cannabidiol, quantity: 100 mg/ml - oral liquid, solution - excipient ingredients: sesame oil; sucralose; ethanol absolute; flavour - epidyolex is indicated for use as adjunctive therapy of seizures associated with lennox-gastaut syndrome (lgs) or dravet syndrome (ds) for patients 2 years of age and older.

New Zealand - English - Medsafe (Medicines Safety Authority)

chiesi new zealand limited t/a emerge health - cannabidiol 100 mg/ml;  ;  ;   - oral solution - 100 mg/ml - active: cannabidiol 100 mg/ml       excipient: ethanol sesame oil strawberry flavour 501094 a sucralose - epidyolex is indicated for use as adjunctive therapy of seizures associated with lennox-gastaut syndrome (lgs) or dravet syndrome (ds) for patients 2 years of age and older.

European Union - English - EMA (European Medicines Agency)

daiichi sankyo europe gmbh - quizartinib dihydrochloride - leukemia, myeloid - antineoplastic agents, protein kinase inhibitors - vanflyta is indicated in combination with standard cytarabine and anthracycline induction and standard cytarabine consolidation chemotherapy, followed by vanflyta single-agent maintenance therapy for adult patients with newly diagnosed acute myeloid leukaemia (aml) that is flt3-itd positive.

Ireland - English - HPRA (Health Products Regulatory Authority)

vet-agro multi-trade company sp z o.o. - dexamethasone sodium phosphate - solution for injection - 2 milligram(s)/millilitre - dexamethasone

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

y.s.p. industries (m) sdn. bhd. - triamcinolone acetonide -

United Kingdom - English - VMD (Veterinary Medicines Directorate)

emdoka bvba - dexamethasone isonicotinate - suspension for injection - anti inflammatory corticosteroid - cats, cattle, dogs, horses, pigs

Ireland - English - HPRA (Health Products Regulatory Authority)

emdoka - dexamethasone isonicotinate - suspension for injection - dexamethasone

United States - English - NLM (National Library of Medicine)

dechra veterinary products - trilostane (unii: l0fpv48q5r) (trilostane - unii:l0fpv48q5r) - trilostane 5 mg - vetoryl capsules are indicated for the treatment of pituitary-dependent and adrenal-dependent hyperadrenocorticism in dogs. the use of vetoryl capsules is contraindicated in dogs that have demonstrated hypersensitivity to trilostane. do not use vetoryl capsules in animals with primary hepatic disease or renal insufficiency (see warnings and precautions ). do not use in pregnant dogs. studies conducted with trilostane in laboratory animals have shown teratogenic effects and early pregnancy loss.